Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GSK1795091 |
Synonyms | |
Therapy Description |
GSK1795091 is a TLR4 agonist, which activates TLR4 leading to increased cytokine production, and potentially resulting in enhanced anti-tumor immune response (PMID: 32739049). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GSK1795091 | GSK-1795091|GSK 1795091 | TLR4 Agonist 2 | GSK1795091 is a TLR4 agonist, which activates TLR4 leading to increased cytokine production, and potentially resulting in enhanced anti-tumor immune response (PMID: 32739049). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|